Unmet needs in the use of CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer
Eva Ciruelos • 16 Mar 2023
IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter